# OnCo record avelos-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/avelos-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "avelos-therapeutics" ;
  schema:name "Avelos Therapeutics"@en ;
  schema:alternateName "Avelos Therapeutics Inc."@en, "AVELOS Therapeutics"@en ;
  schema:description "Avelos Therapeutics is a Seoul company making targeted tablets that exploit weaknesses in how cancer cells divide and repair their DNA. Its first drug, AD1208, blocks a cell-division enzyme called MASTL and is in an early trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/avelos-therapeutics/>, <http://avelostx.com/en/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <http://avelostx.com/en/>, <http://avelostx.com/en/sub/company/history.asp>, <https://clinicaltrials.gov/study/NCT06911333> ;
  schema:addressCountry "KR" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/> ;
  onco:trials <https://onco.cc/trials/nct06911333/> .